Category: Life Sciences
Life Sciences
With the FDA approval, the company would be able to help medical professionals integrate 3D mapping with ablation to advance atrial fibrillation treatment. The approval also further expands the company’s existing cardiac ablation tools portfolio. Abbott Laboratories (Abbott), an American pharmaceutical company, has reportedly announced …
Life Sciences
The collaboration between the two organizations is expected to facilitate deeper insights into Parkinson’s disease as well as its progression. The collaboration would initially run over a one-year period with the aim of developing a disease progression model. International Business Machines Corporation (IBM), the renowned …
Life Sciences
Ohr Pharmaceutical, Inc. has reportedly entered into a merger agreement with NeuBase Therapeutics, under which the latter’s stakeholders would become the majority stockholders of the joint entity. As per trusted sources, the proposed merger will result in a public company committed to the advancement of …
Life Sciences
The U.S.-based privately held clinical-stage specialty pharmaceutical firm, Banner Life Sciences LLC, reportedly declared that its New Drug Application (NDA 505(b)(2)) for BAFIERTAM™ has been tentatively approved by the United States FDA. As per trusted sources, BAFIERTAM™ is known to be a unique fumarate bioequivalent …
Life Sciences
Reports confirm that a revolutionary therapy, known as CAR-T, which treats aggressive blood cancers has been approved for use in Australia. Apparently, this immunotherapy would assist adults in battling a type of aggressive lymphoma and children in fighting leukemia. The therapy has secured an approval …
Life Sciences
Orgenesis Inc., has reportedly announced a collaboration with MangoGen Pharma Inc., aimed at pre-clinical development of insulin-producing cells through MangoGen’s innovative gene delivery platform. As per trusted sources, the collaboration will see the two companies collectively develop and complete solution to deliver insulin-producing cells to …
Life Sciences
Johnson & Johnson’s psoriasis treatment Tremfya has reportedly been found more effective than Novartis’s Cosentyx for treating moderate to severe stages of the condition, unveiled findings from the phase 3 study. As per trusted sources, in a phase 3 trial at the 48-week mark, 84.5% …
Life Sciences
Bristol-Myers Squibb and non-profit biotech firm LabCentral have reportedly announced Strand Therapeutics and ReviveMed as the winners of Bristol-Myers Squibb’ 2018 Golden Tickets for LabCentral. Bristol-Myers Squibb, as a platinum sponsor of LabCentral, is liable to choose up to two innovative biotech and life-sciences startup …
Life Sciences
UK’s national healthcare system, NHS (National Health Service) is set to make a record-breaking £300 million saving after reaching deals with five manufacturers on low-cost versions of its most costly drug, adalimumab. Sources close to the matter claim that the deal should save hospitals £300m, …